Zobrazeno 1 - 10
of 10
pro vyhledávání: '"S V, Model"'
Autor:
A E Misyurina, S K Kravchenko, Ya K Mangasarova, A U Magomedova, A M Kovrigina, L T Shimanovskaya, E A Fastova, V A Misyurin, S V Model, D I Chebotarev, I E Kostina, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 91, Iss 4, Pp 107-113 (2019)
Mediastinal gray-zone lymphoma (MGZL, lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma) was declared as a separate entity in WHO classification of Tumors of Haematopoetic and Lymphoid Tissues in
Externí odkaz:
https://doaj.org/article/7cbcda28488c4a5181098ce8cb8dfb7b
Autor:
R V PONOMAREV, S V MODEL, N I ZOZULYA, V A IVANOV, D A PODCHASOV, E A MERSHINA, V E SINITSYN, E A LUKINA
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 86-90 (2018)
Constrictive pericarditis (CP) is the final stage of a chronic inflammatory process characterized by fibrous thickening and calcification of the pericardium that impairs diastolic filling, reduces cardiac output, and ultimately leads to heart failure
Externí odkaz:
https://doaj.org/article/7238e29b652f4a0ea1fa53e41c46e6e6
Publikováno v:
Терапевтический архив, Vol 89, Iss 10, Pp 71-74 (2017)
Gaucher disease is the most common form of hereditary enzymopathies combined into a group of lysosomal storage diseases. The basis for the disease is a hereditary deficiency of the activity of acid β-glucosidase, a lysosomal enzyme involved in the c
Externí odkaz:
https://doaj.org/article/b9231b1af7c64d6180a57c17d8dfa532
Autor:
G M Galstyan, O A Polevodova, A Yu Gavrish, T Yu Polyanskaya, V Yu Zorenko, M S Sampiev, L S Biryukova, S V Model, L A Gorgidze, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 76-84 (2017)
The paper describes 4 clinical cases of thrombotic events (pulmonary embolism, deep vein thrombophlebitis, acute myocardial infarction, ischemic stroke) that have occurred in patients with hemophilia. It discusses the possible causes of their develop
Externí odkaz:
https://doaj.org/article/949a7dffa14449d19f08c89ce4b630f1
Autor:
A N Sokolov, E N Parovichnikova, V С Isaev, Е N Ustinova, V S Shavlokhov, V A Atopkov, S V Model, N N Tsyba, I В Kaplanskaya, G A Klyasova, M Zh Aleksanyan, E S Vishnevskaya, D K Togonidze, E E Mirzoyan, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 79, Iss 12, Pp 73-75 (2004)
Externí odkaz:
https://doaj.org/article/d3f9ab7d492a4ab485575154c71a29f5
Autor:
Aminat U. Magomedova, V. A. Misyurin, S V Model, Ya K Mangasarova, L T Shimanovskaya, V G Savchenko, A E Misyurina, I. E. Kostina, Alla M. Kovrigina, D I Chebotarev, E A Fastova, S K Kravchenko
Publikováno v:
Терапевтический архив, Vol 91, Iss 4, Pp 107-113 (2019)
Mediastinal gray-zone lymphoma (MGZL, lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma) was declared as a separate entity in WHO classification of Tumors of Haematopoetic and Lymphoid Tissues in
Autor:
A H, Sokolov, E N, Parovichnikova, V G, Isaev, E N, Ustinova, V S, Shavlokhov, V A, Atopkov, S V, Model, N N, Tsyba, I B, Kaplanskaia, G A, Kliasova, M Zh, Aleksanian, E S, Vishnevskaia, D K, Togonidze, E E, Mirzoian, V G, Savchenko
Publikováno v:
Terapevticheskii arkhiv. 76(12)
Publikováno v:
Terapevticheskii arkhiv. 74(5)
To investigate whether plasma replacement (PR) can raise efficiency of drug therapy of ischemic heart disease (IHD).A 30-60% replacement of circulating plasma for salt or dextran using PF-05 unit has been performed in 324 patients 35-79 years of age
Publikováno v:
Kardiologiia. 31(9)
Plasmapheresis on a continuous blood flow fractionator to remove 1,200-2,000 ml plasma and substitute for the same values of dextran solutions was employed in the multi-modality treatment of 25 patients with Functional Classes II-IV exertional angina
Publikováno v:
Kardiologiia. 30(8)
The bicycle ergometric test was used to examine exercise tolerance in 73 patients with coronary heart disease following a single remedial plasmapheresis session, which removed an average of 1562.2 ml plasma. A rapid increase in exercise tolerance was